Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia.
We studied telomere length in the peripheral blood leukocyte samples of a large group of patients with chronic myelogenous leukemia (CML) by Southern blot hybridization using the (TTAGGG)4 probe. The average telomere length expressed as the peak telomere repeat array (TRA) of the peripheral blood sa...
Main Authors: | Boultwood, J, Fidler, C, Shepherd, P, Watkins, F, Snowball, J, Haynes, S, Kusec, R, Gaiger, A, Littlewood, T, Peniket, A, Wainscoat, J |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
1999
|
Registos relacionados
-
Analysis of telomere length in chronic myelogenous leukemia.
Por: Boultwood, J, et al.
Publicado em: (1997) -
Analysis or telomere length in chronic myelogenous leukemia
Por: Fidler, C, et al.
Publicado em: (1998) -
Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.
Por: Boultwood, J, et al.
Publicado em: (2000) -
Telomere length shortening in CML is associated with reduced time to accelerated phase but does not influence overall survival.
Por: Boultwood, J, et al.
Publicado em: (1999) -
Telomere length in myelodysplastic syndromes.
Por: Boultwood, J, et al.
Publicado em: (1995)